Atrys Health Sl Stock Three Year Return
ATRY Stock | EUR 3.09 0.05 1.59% |
Atrys Health SL fundamentals help investors to digest information that contributes to Atrys Health's financial success or failures. It also enables traders to predict the movement of Atrys Stock. The fundamental analysis module provides a way to measure Atrys Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atrys Health stock.
Atrys |
Atrys Health SL Company Three Year Return Analysis
Atrys Health's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
Competition |
Based on the latest financial disclosure, Atrys Health SL has a Three Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Spain stocks average (which is currently at 0.0).
Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
Atrys Fundamentals
Return On Equity | -0.0723 | |||
Return On Asset | 0.0022 | |||
Profit Margin | (0.13) % | |||
Operating Margin | 0.01 % | |||
Current Valuation | 647.57 M | |||
Shares Outstanding | 75.89 M | |||
Shares Owned By Insiders | 78.47 % | |||
Shares Owned By Institutions | 11.00 % | |||
Price To Book | 1.28 X | |||
Price To Sales | 2.47 X | |||
Revenue | 121.01 M | |||
Gross Profit | 27.78 M | |||
EBITDA | 6.88 M | |||
Net Income | (23.25 M) | |||
Cash And Equivalents | 17.6 M | |||
Cash Per Share | 0.51 X | |||
Total Debt | 146.81 M | |||
Debt To Equity | 0.95 % | |||
Current Ratio | 1.74 X | |||
Book Value Per Share | 4.67 X | |||
Cash Flow From Operations | 4.69 M | |||
Earnings Per Share | (0.46) X | |||
Target Price | 10.46 | |||
Number Of Employees | 2.4 K | |||
Beta | 0.37 | |||
Market Capitalization | 461.42 M | |||
Total Asset | 565.63 M | |||
Z Score | 1.8 | |||
Net Asset | 565.63 M |
About Atrys Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atrys Health SL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atrys Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atrys Health SL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Atrys Stock
Atrys Health financial ratios help investors to determine whether Atrys Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Atrys with respect to the benefits of owning Atrys Health security.